Integer (NYSE:ITGR) Announces Quarterly Earnings Results, Beats Expectations By $0.22 EPS

Integer (NYSE:ITGR) issued its quarterly earnings results on Monday. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.38 by $0.22, FiscalAI reports. The company had revenue of $464.11 million during the quarter, compared to the consensus estimate of $451.07 million. Integer had a return on equity of 12.77% and a net margin of 6.97%.Integer’s revenue was down 2.6% on a year-over-year basis. During the same period last year, the company earned $1.55 earnings per share.

Integer Stock Performance

ITGR stock opened at $124.94 on Wednesday. Integer has a twelve month low of $62.00 and a twelve month high of $125.54. The firm has a market cap of $4.24 billion, a price-to-earnings ratio of 31.16, a PEG ratio of 2.97 and a beta of 0.61. The business’s fifty day simple moving average is $95.27 and its two-hundred day simple moving average is $89.56. The company has a quick ratio of 2.38, a current ratio of 3.75 and a debt-to-equity ratio of 0.77.

Integer News Summary

Here are the key news stories impacting Integer this week:

• Positive Sentiment: KKR agreed to acquire Integer in an all-cash transaction valued at approximately $5.7 billion. Stockholders would receive $127 per share, representing a 51.8% premium to the price before Integer announced its strategic review and a 28.8% premium to the 30-day volume-weighted average price. The deal is expected to close by year-end 2026, subject to shareholder and regulatory approvals. Integer to Be Acquired by KKR
• Positive Sentiment: KKR’s backing is expected to give Integer additional capital and flexibility to invest in manufacturing capacity, technology, innovation and talent. The private-equity firm also plans an employee ownership program, potentially supporting retention and productivity. Integer Holdings KKR Deal
• Positive Sentiment: Integer’s second-quarter results exceeded expectations: adjusted earnings were $1.60 per share versus the $1.38 consensus estimate, while revenue of $464.1 million topped the $450.7 million estimate. Earnings also improved from $1.55 per share a year earlier. Integer Second Quarter 2026 Results
• Neutral Sentiment: Wells Fargo raised its price target from $84 to $127 but maintained an “equal weight” rating, leaving little implied upside beyond the proposed transaction price. Wells Fargo Price Target Update
• Negative Sentiment: Truist downgraded Integer from “strong buy” to “hold,” reflecting the stock’s proximity to the $127 offer and limited potential upside if the deal closes. Truist Downgrade
• Negative Sentiment: Revenue declined 2.6% year over year, and Integer withdrew its financial outlook and canceled its planned earnings call because of the pending acquisition. Several law firms are also investigating whether shareholders are receiving a fair price, creating potential deal-related uncertainty. Shareholder Investigation

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in ITGR. T. Rowe Price Investment Management Inc. increased its stake in Integer by 800,382.9% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 280,169 shares of the medical equipment provider’s stock worth $21,974,000 after buying an additional 280,134 shares during the period. Corient Private Wealth LLC purchased a new stake in Integer in the 4th quarter valued at about $535,000. Mercer Global Advisors Inc. ADV boosted its position in Integer by 1.4% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 41,049 shares of the medical equipment provider’s stock valued at $3,219,000 after buying an additional 555 shares during the period. XTX Topco Ltd bought a new position in Integer in the 4th quarter worth about $4,581,000. Finally, Voloridge Investment Management LLC bought a new position in Integer in the 4th quarter worth about $14,694,000. 99.29% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages have recently weighed in on ITGR. Piper Sandler downgraded shares of Integer from an “overweight” rating to a “hold” rating and set a $127.00 target price on the stock. in a research note on Monday. Raymond James Financial cut shares of Integer from a “moderate buy” rating to a “hold” rating in a research note on Monday. Wells Fargo & Company upped their price target on shares of Integer from $84.00 to $127.00 and gave the company an “equal weight” rating in a report on Tuesday. Citigroup increased their price objective on shares of Integer from $92.00 to $96.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 8th. Finally, HC Wainwright reissued a “buy” rating on shares of Integer in a research note on Friday, July 24th. One investment analyst has rated the stock with a Buy rating and thirteen have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $109.86.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.